The burgeoning field of radiopharmaceuticals, propelled by the success of treatments like Novartis’s Pluvicto (lutetium Lu 177 vipivotide tetraxetan), is…
Read More
Recent Biotech Bi-Weekly Highlights Breakthroughs in Alzheimer’s Modeling and Lab Automation, Fueling Drug Discovery Hopes
In a significant development for neurodegenerative disease research, 28bio, a biotechnology firm based in Los Angeles, USA, has announced the…
Read More
The journal at a glance: Q1 2026 highlights from our Editor in Chief
Chapel Hill, NC – Michelle Itano, the esteemed Editor-in-Chief hailing from the University of North Carolina, Chapel Hill, has unveiled…
Read MoreYOU MAY HAVE MISSED
